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A B S T R A C T
The monetary value of a quality-adjusted life-year (QALY) is frequently used to assess the beneﬁts of health
interventions and inform funding decisions. However, there is little consensus on methods for the estimation of
this monetary value. In this study, we use life satisfaction as an indicator of ‘experienced utility’, and estimate
the dollar equivalent value of a QALY using a ﬁxed eﬀect model with instrumental variable estimators. Using a
nationally-representative longitudinal survey including 28,347 individuals followed during 2002–2015 in
Australia, we estimate that individual's willingness to pay for one QALY is approximately A$42,000-A$67,000,
and the willingness to pay for not having a long-term condition approximately A$2000 per year. As the estimates
are derived using population-level data and a wellbeing measurement of life satisfaction, the approach has the
advantage of being socially inclusive and recognizes the signiﬁcant meaning of people's subjective valuations of
health. The method could be particularly useful for nations where QALY thresholds are not yet validated or
established.
1. Introduction
The methods for assigning monetary value to health or quality-ad-
justed life-years (QALYs) form the foundation of the modern applica-
tion of cost-eﬀectiveness analysis, where a threshold is used to de-
termine whether an intervention is cost-eﬀective and the resulting
recommendations for funding. A recent systematic review on will-
ingness to pay for a QALY (Ryen and Svensson, 2015) identiﬁed 24
published studies, with the overwhelming majority using the stated
preference method, such as various forms of contingent valuation
which uses hypothetical questions to directly ask about individual's
willingness to pay to move between health states. As the review by
Ryen and Svensson (2015) highlights these studies have produced a
wide range of estimates for the willingness to pay for a QALY with a
mean across all studies being €118,839 and a median of €24,226.
A diﬀerent, but growing literature uses subjective wellbeing va-
luation methods to calculate the shadow price of health. Compared
with stated preference methods which rely on expected utility under
hypothetical scenarios, the well-being valuation method examines the
impacts of life circumstances based on revealed preference (for a more
detailed discussion on stated and revealed preference methods, see for
instance Dolan and Kahneman, 2008; Mark and Swait, 2004; and
McPherson et al., 2004). Examples of well-being valuation studies in-
clude Ferrer-i-Carbonell and van Praag (2002), Groot and van den Brink
(2004), Powdthaveea and van den Berg (2011), Oswald and
Powdthavee (2008) and McNamee and Mendolia (2014) where the
equivalent income for speciﬁc diseases, disabilities and pains was es-
timated. The wellbeing valuation method has also been used to mon-
etarize other non-market commodities such as marriage, crime and
informal care (see for instance, Clark and Oswald, 2002; Moore and
Shepherd, 2006; van den Berg and Ferrer-i-Carbonell, 2007). Typically
for this approach, a measure of subjective wellbeing is regressed on
income and health conditions along with other socio-economic vari-
ables. The trade-oﬀs between income and the health conditions are then
estimated so that the income equivalence that is necessary for the in-
dividual to achieve the level of wellbeing before health deterioration
can be approximated.
To date the wellbeing valuation studies in health have focused on
broad categories of disease such as migraine and diabetes (Groot and
van den Brink, 2004; Powdthaveea and van den Berg, 2011), which
limit its applicability in economic evaluation where the most common
outcome is to measure health using generic preference-based measures
such as QALYs.
This study advances the wellbeing valuation method and uses
general life satisfaction with a generic measure of health, the short form
6-dimensions (SF-6D), to estimate the dollar value of a QALY. Unlike
previous wellbeing valuation studies where either a monetary com-
pensation (also termed willingness to accept) was estimated or a gen-
eral equivalent income was presented without further distinctions on
willingness to pay or accept, we explicitly provided an estimate of
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T
willingness to pay using an instrumental variable approach. Also, by
using the SF-6D which is a preference-based health measure that can be
used to describe more than 18,000 health states and generate QALYs
(Whitehurst et al., 2011), we extended the potential empirical appli-
cation of the wellbeing valuation method from monetarizing speciﬁc
illnesses to monetarizing various conditions. Hence, with the estimated
willingness to pay, we are attempting to facilitate a net-beneﬁt ap-
proach to economic evaluation.
The rest of the paper is organized as follows: Section 2 introduces
the conceptual framework. Section 3 describes the empirical method
and the data. Section 4 presents the results and examples of how the
results can be applied. Section 5 concludes.
2. Conceptual framework
For simplicity, we assume that an individual's wellbeing depends on
income y and health h. The individual's wellbeing in period t can be
described as
=W W Y H( , )it it it
where Yit is a vector of incomes yit from the past up till the present,
hence allowing incomes from the past to aﬀect current wellbeing, for
instance via savings or adaptation; Hit is a vector of health outcomes hit
from the past till the present, allowing past health to aﬀect current
outcomes, for instance via eﬀects on social capital or adaptation.
We can deﬁne the wellbeing an individual experiences in a T-year
interval as
∑=
=
W Y H W Y H( , ) ( , )i i i
t
T
it it
0
where T could be a year, a decade, or a whole lifetime and Y Handi i
now denotes income and health over the whole time-span. Consider
then an individual who experiences a change in their health vector ΔHi
in this T-year window. The income change ΔYi that is equivalent to this
health change is now the income change that holds wellbeing constant
and thus solves
= + +W Y H W Y ΔY H ΔH( , ) ( , )i i i i i i i (1)
Now, because the equivalence holds for the sum of wellbeing over
the T-year window, there are in principle an inﬁnite number of vectors
ΔYi that equalize a health change and thus could constitute a will-
ingness to pay. One important scenario is a lump-sum payment for a
particular health improvement over the T-year rolling window, and the
payment could be made at either the start or end of the T-year rolling
window. We are also interested in the willingness to pay in the current
year (or the most recent year of the T-year rolling window) for a sus-
tained health improvement still enjoyed in the current year, which
represents the long-run equilibrium payment for a sustained health
improvement.
It is important to realize that equation (1) will be measured by using
levels of wellbeing experienced, rather than anticipated levels of well-
being. Hence, we identify the equivalent income that maintains well-
being therefore measuring the willingness to pay of a ‘rational’ in-
dividual.
3. Empirical methods
3.1. Model
In the model to be considered, we use a T-year rolling window
(T= 2) of variables
= + ⋅ − + ⋅ − + ⋅ + ⋅ +
⋅ + ⋅ + ⋅ + + +
− −
−
LS a b SF D b SF D c LTC c LTC d
Y d Y g X λ δ u
6 6it it it it it
it it it i t it
0 1 1 0 1 1 0
1 1 (2)
where LSit refers to the life satisfaction for individual i in time
−t SF D, 6 it is the generic health utility score, LTCit is a dummy vari-
able indicating long term health conditions (termed LTC), Yit is the
equivalised household income of the individual at time t where
equivalised income was obtained by weighting the household income
by how many members are in the household with a weight of 1 applied
to ﬁrst adult, 0.5 to an additional adult and 0.3 to each child
(Hagenaars et al., 1994); λi is an unobserved time invariant individual
factor, δt is a year ﬁxed eﬀect, and uit is an error term. A conventional
vector of other socio-economic variables that could have an impact on
life satisfaction is included and represented by Xit , which incorporates
age, marital status, education, leisure capacity, and unemployment.
Here health is described by the SF-6D and LTC, and willingness to
pay approximated by income. We have chosen a rolling window of
T= 2 years (t and t-1) to allow for the estimation of a willingness to pay
over a relatively short period of time, as well as the capture of adap-
tation eﬀect of income and health (see Appendix Method S1 for an il-
lustration of the equations for T=3 [INSERT LINK TO ONLINE FILE
A]). With the dynamic speciﬁcation, the eﬀect of a health utility change
is described by +b b0 1 and the total eﬀect in accumulated health utility
over the 2-year window is then ∗ + − ∗b bT (T 1)0 1 . Similarly for the
eﬀects of a LTC where the total accumulated eﬀect of a change is
∗ + − ∗c cT (T 1)0 1.
The dynamic speciﬁcation also allows us to compare the importance
of income and health changes over time: the total eﬀect of a permanent
income change is +d d0 1 per dollar per year and a permanent health
change is + +b b c cand0 1 0 1.
Therefore, the amount of money that individuals should be willing
to give up for a health change given a constant level of
+ + +…+− − − +LS LS LS LS( )it it it it1 2 T 1 can be estimated as follows. The
average willingness to pay per year for maximum health utility im-
provement (hence = =ΔSF D Δ‐6 1 or QALY 1 based on the interval
scale property of SF-6D and the annual structure of HILDA) and for not
having a long-term health condition = −ΔLTC( 1), which we term
WTP and WTPS L , in the T-year window (T= 2) can be estimated as:
= ∗ + − ∗ ∗ + − ∗b b d dWTP ((T (T 1) )/(T (T 1) )S 0 1 0 1
= ∗ + − ∗ ∗ + − ∗c c d dWTP ((T (T 1) )/(T (T 1) )L 0 1 0 1 (3)
In terms of the long-run equilibrium for a sustained health im-
provement, the willingness to pay is estimated as:
= + +LR b b d dWTP ( )/( )S 0 1 0 1
= + +LR c c d dWTP ( )/( )L 0 1 0 1 (4)
3.2. An instrumental variable approach
A major concern of our empirical strategy as described by equation
(2) is that, when one controls for time invariant individual traits (ﬁxed
eﬀects) which could be correlated with both life satisfaction and in-
come, the estimates are largely inﬂuenced by income changes that are
prone to high measurement error. Measurement error could arise from
income changes that people are unaware of or would not interpret as
meaningful, such as changes due to an updated pension policy or in-
ﬂation. We also have some concern over the asymmetry eﬀect of in-
come on wellbeing, namely that the eﬀect of a loss of one dollar is
generally greater than the eﬀect of a gain of one dollar (Tversky and
Kahneman, 1991), implying that forcing income to have a single coef-
ﬁcient over loss and gain could bias the estimated willingness to pay
upwards.
Owing to the strong likelihood of an endogeneity bias of income due
to measurement error, an instrumental variable is required. We use ﬁ-
nancial worsening event which is available from the HILDA survey as
instrument for income as inspired by Mervin and Frijters (2014) and
Frijters et al. (2011). Financial worsening event is by deﬁnition corre-
lated with income and can be assumed to aﬀect life satisfaction through
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its negative impact on income. Using ﬁnancial worsening as instrument
ensures that the wellbeing eﬀect of income is measured through the
ﬁnancial changes that people recognize, and that we are not basing our
estimates on measurement errors in income. Also, ﬁnancial worsening
resembles expense (or willingness to pay) rather than compensation (or
willingness to accept) and thus addresses the problem of an asymmetric
eﬀect of income. Our dynamic speciﬁcation with the instrumental
variable strategy, as indicated in Frijters et al. (2011), by-passes the
well-known diﬃculties of correctly estimating the importance of in-
come for life satisfaction (for a summary of these diﬃculties see Clark
et al., 2008).
More speciﬁcally, we instrument the two income variables in (2)
with − −FW FW FW FW, and , whereit it it it1 denotes whether an event of
ﬁnancial worsening took place last year, and −FWit whether the ﬁ-
nancial worsening shock took place in any year > two years ago
(which captures the longer-term eﬀect of a ﬁnancial worsening).
To test the quality of the instruments statistically, we use the Cragg-
Donald Wald F statistic and Stock and Yogo critical values (for weak
instruments), Anderson canonical correlations likelihood-ratio test (for
under identiﬁcation), Hansen-Sargan test (for over identiﬁcation), and
an endogeneity test of the endogenous variables.
3.3. Data
For the empirical analysis, we use the Household, Income and
Labour Dynamics in Australia (HILDA) survey, which is a longitudinal
household panel that is nationally representative with the exception of
under-sampling people living in remote and sparsely populated areas.
Beginning in 2001, HILDA contains over 10,000 individuals who are at
least 15 years of age at the time of the interview from more than 7000
households. We use all waves where our variables of interest including
ﬁnancial worsening are available (waves 2 to 15), covering 14 years of
data from 2002 to 2015. HILDA Survey is funded by the Department of
Social Services (Australia) and is managed by the Melbourne Institute,
and was approved by the Human Research Ethics Committee at the
University of Melbourne (1647030). Appropriate approval was ob-
tained for this study from the Department of Social Services to access
the publicly available, de-identiﬁed longitudinal dataset.
Life satisfaction is assessed using the response to the question “All
things considered, how satisﬁed are you with your life?”, scored as ‘10’
if they are totally satisﬁed, and ‘0’ if totally dissatisﬁed. The distribution
of the responses to this question are negatively skewed, with approxi-
mately 70% of the responses scored as 8 and above. The SF-6D scores in
HILDA are derived from the short form 36 (SF-36) (Summerﬁeld et al.,
2016). SF-6D is composed of six multi-level dimensions including
physical functioning, role limitations, social functioning, pain, mental
health and vitality. It has interval scale property and is anchored at 1
for full health and 0 for dead (Brazier et al., 2002), although the ranges
of index values are on a 0.301 to 1. The distribution of the SF-6D scores
from HILDA is negatively skewed with the median scores being 0.795.
The distributions of life satisfaction and the SF-6D scores are illustrated
in the Appendix (Figure S1 [INSERT LINK TO ONLINE FILE B]).
HILDA also identiﬁed people with long-term health conditions using
the question “Looking at showcard K1, do you have any long-term
health condition, impairment or disability (such as these) that restricts
you in your everyday activities, and has lasted or is likely to last, for 6
months or more?”. 27% of the person-year responses are “Yes” across
all 14 waves. Responses for ﬁnancial worsening events are elicited
using the following question: “Did any of these happen to you in the
past 12 months? Major worsening in ﬁnancial situation (e.g., went
bankrupt)”. 3% of the person-year responses are “Yes”, which re-
presents 13% of the respondents who in some year have had a major
worsening. Put diﬀerently, although on average only 3% of people have
a ﬁnancial worsening in each wave, across waves ﬁnancial worsening
happens to 13% of the population at least once. We checked whether
these respondents looked very diﬀerent since their ﬁnancial shocks
drive the main results. Their mean age, gender, marriage rate, educa-
tion and leisure capacity were all within 5% of those who never had a
ﬁnancial worsening.
After excluding 140 observations with life satisfaction response
missing, our sample consists of 203,808 person-year responses corre-
sponding to 28,347 individuals. The key characteristics of the sample
are summarised in Table 1.
4. Results
4.1. Base case results
The ﬁxed eﬀect model results with and without IV are reported in
Table 2. For the model with IV, a Cragg-Donald F value of 17.25 rejects
the null that our instruments are weak. The Anderson test suggests that
Table 1
Key characteristics of the sample at person-year response level.
Mean SD Measure
Life satisfaction 7.9 1.5 0-10, 0 totally dissatisﬁed, 10
totally satisﬁed
Equivalised household
incomea(A$1000)
50.872 42.494 −2452.200–1021.406
SF-6D 0.761 0.123 0.301–1
Long-term conditions 0.274 0.446 0 no, 1 yes
Financial worsening 0.031b 0.173 0 no, 1 yes
Age 44.3 18.7 15–101
Married/de facto 0.619 0.486 0 no, 1 yes
Education 2.0 0.8 0-3, 1 less than Year 12, 2 Year 12
or equivalent, 3 bachelor or
above
Leisure capacityc 0.362 0.458 0 no, 1 yes
Unemployment 0.038 0.191 0 no, 1 yes
a All incomes are converted to 2015 Australian dollar price. Negative
equivalised household incomes are included to allow the full impact of ﬁnancial
worsening to be demonstrated. A negative response could arise when house-
holds incur losses in their unincorporated business or have negative returns
from their other investments (Australian Bureau of Statistics, 2015).
b At individual level, 13% of the individuals have reported ﬁnancial wor-
sening events in one or more waves.
c Leisure capacity is approximated using the percentage of time not in paid
employment in the last ﬁnancial year.
Table 2
Estimated eﬀects on life satisfaction.
Fixed eﬀect, no IV Fixed eﬀect, with IV
Income in 1000's 0.0006∗∗ (0.0001) 0.080∗∗ (0.010)
Income in 1000's, a year ago 0.0004∗∗ (0.0001) −0.035∗∗ (0.010)
SF-6D 2.432∗∗ (0.037) 2.258∗∗ (0.134)
SF-6D, a year ago 0.749∗∗ (0.037) 0.778∗∗ (0.136)
Long-term condition −0.089∗∗ (0.009) −0.153∗∗ (0.034)
Long-term condition, a year ago −0.005 (0.009) 0.057 (0.034)
Age −0.025 (0.015) 0.001 (0.056)
Age squared 0.0004∗∗ (0.000) 0.001∗∗ (0.000)
Married/ de facto 0.296∗∗ (0.013) −0.012 (0.066)
Education −0.086∗∗ (0.014) −0.099 (0.054)
Leisure capacity 0.042∗∗ (0.012) 0.734∗∗ (0.102)
Unemployment −0.170∗∗ (0.019) −0.225∗∗ (0.068)
No. of observations 134,224 106,457
Test statistics
Cragg-Donald 17.25
(Stock and Yogo 10% maximal IV size critical value: 13.43)
Anderson (χ2) 51.72
Sargan (χ2) 0.16
Endogeneitya (χ2) 588.99
∗0.05 **0.001. Standard errors in parentheses. Year-dummy coeﬃcients are
omitted.
a Diﬀerence of two Sargan-Hansen statistics.
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the equation is identiﬁed, and the Sargan statistic cannot reject the null
that the instruments are valid. The endogeneity test rejects the null that
income can be treated as exogenous. Overall, the test statistics suggest
that an instrument for income is needed in the ﬁxed eﬀects model and
that the choice of ﬁnancial worsening is appropriate. The ﬁrst stage
results of the model with IV are reported in the Appendix (Table S1
[INSERT LINK TO ONLINE FILE C]), conﬁrming that ﬁnancial wor-
sening and income have a statistically signiﬁcant correlation thus our
instrument is not weak. The ﬁrst stage results also show that the eﬀect
of an average ﬁnancial worsening relates to an accumulated income loss
of approximately A$23,000 over a 2-year period.
As shown in Table 2, income is estimated to have a statistically
signiﬁcant impact on life satisfaction for both ﬁxed eﬀect models,
however the eﬀect of income is much larger in the model with IV in-
dicating that endogeneity of income and measurement error are ad-
dressed. The magnitudes of the income coeﬃcients with IV (Table 2)
indicate that on average, a one-oﬀ income loss of A$10,000 lowers life
satisfaction by about 0.5 unit on the scale over a 2-year rolling window,
with life satisfaction drops by 0.8 in the ﬁrst year and bounds back by
0.3 in the second year. A sustained decrease in equivalised disposable
income of A$10,000 lowers life satisfaction by about 1.25 unit on the
scale over 2 years, with life satisfaction drops by 0.8 in the ﬁrst year and
drops a further 0.45 in the second year.
The wellbeing impact of health, as represented by SF-6D and long-
term condition status, are also statistically signiﬁcant except for the
long-term condition status ‘a year ago’, conﬁrming that individual's life
satisfaction rises as health improves and falls when it declines. The
magnitudes of the health utility coeﬃcients with IV (Table 2) indicate
that on average, a 0.2 sustained increase in health utility raises life
satisfaction by about one unit on the scale holding all other factors
constant.
Using formulas (3) and (4) in Section 3.1, it is estimated that the
average willingness to pay for one QALY is approximately A$42,000
over a 2-year rolling window, and A$67,000 in the long run for a
sustained health improvement (Table 3, base case). The long-run will-
ingness to pay for a sustained health improvement is estimated to be
larger as individuals adapt to a sustained change in income (ex-
empliﬁed by the negative coeﬃcient on lagged income) whilst we see
the opposite for SF-6D (the eﬀect of lagged SF-6D is positive indicating
that the eﬀect accumulates). In other words, people discount money
diﬀerently from health. The willingness to pay per year for not having a
long-term condition is estimated to be around A$2000 holding health-
related quality of life constant. This suggests that having a long-term
condition penalises life satisfaction even if the condition has similar
impacts on quality of life as a temporary condition. Perhaps this is due
to the inconvenience and worry associated with a long-term condition,
or that people think the conditions will get worse the longer they last.
4.2. Robustness tests
To test the robustness of the results, a number of alternative spe-
ciﬁcations are examined. We ﬁrst check the impact of using diﬀerent
data periods on the estimated willingness to pay, the impact of limiting
data to wave 2–13 (older data) and then wave 4–15 (more con-
temporary data) respectively. We then use personal disposable income
instead of equivalised household income, controlling for the number of
adults and children in the household. Next we examine the cases when
negative equivalised household income are dropped and when loga-
rithm transformation of income is used (willingness to pay per QALY is
reported at the median level of income for the logarithm transforma-
tion). We also calculate the willingness to pay for gender subgroups and
for people aged 30 and above (dropping those who are very young thus
less likely to have health concerns). The results are summarised in
Table 3.
As shown in Table 3, when more contemporary data (wave 4–15)
are used willingness to pay estimates are slightly higher compared with
when older data (wave 2–13) are used, although both results are very
close to the base case, indicating that our method has the potential to be
used to update QALY thresholds as time passes by. When personal
disposable income instead of equivalised household income is used,
willingness to pay is estimated to be slightly lower and still close to the
base case. When only positive income and logarithm of income are
Table 3
Base case results and robustness tests.a
Base case (ﬁxed
eﬀect with IV,
wave 2–15)
Older data
(wave 2–13)
Newer data
(wave 4–15)
Personal
income
Personal income
(number of persons
controlled for)
Positive
income only
Log income Subgroups
Men Women Age> 30
Estimated coeﬃcients
Income in 1000’s 0.08** 0.08** 0.08** 0.09** 0.09** 0.09** 4.96** 0.07** 0.08** 0.07**
Income in 1000’s, a
year ago
−0.03** −0.03* −0.04** −0.04* −0.04* −0.04** −1.68** −0.04* −0.03 −0.03*
SF-6D 2.26** 2.22** 2.23** 2.48** 2.48** 2.22** 2.23** 2.16** 2.42** 2.24**
SF-6D, a year ago 0.78** 0.74** 0.80** 0.87** 0.87** 0.77** 0.55** 1.05** 0.57** 0.80**
Long-term
condition
−0.15** −0.16** −0.16** −0.17** −0.17** −0.16** −0.13** −0.20** −0.10* −0.13**
Long-term
condition, a
year ago
0.06 0.05 0.05 0.07 0.08 0.05 0.07* 0.09 0.02 0.06
Willingness to pay (A$)
2-year rolling window
1 QALY 42,250 41,976 45,602 41,021 41,044 39,066 35,954 53,516 38,185 45,718
Long-term
condition
premium
1985 2160 2332 1832 1815 2005 1021 2978 1347 1859
Long-run equivalence
1 QALY 67,022 62,763 75,619 64,974 65,088 66,099 57,242 102,038 51,805 71,696
Long-term
condition
premium
2113 2317 2716 1803 1767 2373 833 3305 1503 1883
a Statistical tests as speciﬁed previously suggest that the instruments are valid in all alternative scenarios presented and reject that the instruments are weak at
10% or 15% Stock and Yogo maximal IV size except for the subgroup of women where the null that the instruments are weak is rejected at 20% maximal IV size.
*0.05 **0.001.
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used, willingness to pay estimates are visibly smaller as observations
with ﬁnancial worsening events that reduce income to negative are
excluded, causing the income impact of ﬁnancial worsening to be
limited.
We also found some heterogeneity in the willingness to pay across
sub-populations. More speciﬁcally, our results suggest that men on
average are likely to be willing to pay more for health compared to
women, mainly owning to a larger overall impact of health relative to
income and a slower adaptation to health changes. When limiting the
sample to people aged 30 and above, average willingness to pay for a
QALY is estimated to be larger, due to that health utility appears to
have a relatively bigger impact on life satisfaction compared to income
when younger people were dropped. These results suggest that popu-
lation characteristics matter to the estimated willingness to pay due to
the diﬀerence in the perceived wellbeing value of health and income.
One worry would be that ﬁnancial worsening is related to other
negative shocks such as relationship strain or losing a job, and that it
would thus capture more negative eﬀects than merely the loss of in-
come. To this end, we ran additional speciﬁcations including indicators
of whether someone was ﬁred the last year or separated from their
partner. Adding these in as controls made no diﬀerence larger than 5%
to the estimated willingness to pay. We have also tested the setting
when T=3. It appears that further lags for income and health were
neither statistically or economically signiﬁcant. Also, due to the limited
impact of ﬁnancial worsening further back, instrumental variable was
rendered weak.
Finally, there is the issue of measurement error and reverse caus-
ality in the SF-6D. Measurement error in the case of the SF-6D, which is
derived from 11 items of the SF-36, is likely to be less of a concern than
with single-item questions. Nevertheless, we ran regressions with
random eﬀects rather than ﬁxed eﬀects, in which case the health
coeﬃcients also include the eﬀects of the variation across individuals,
which reduces reliance on changes in health and thus reduces any
importance of measurement error. We ﬁnd only modest changes in the
coeﬃcient of the SF-6D, indicating that measurement error is likely to
be small in our dataset relative to true changes in health.
4.3. Applications
To demonstrate how the willingness to pay estimates could be ap-
plied, we use three studies from the literature and estimate the dollar
equivalent values of the temporary and long-term health conditions or
disease prevention. The base case estimates are applied in all the ex-
amples. These are intended to provide illustrative examples of how our
estimates can be used in practice.
First, we use the study by Bilcke et al.(2014) in which the QALY
impact of inﬂuenza-like-illness and ﬂu was estimated using the SF-6D.
We apply the willingness to pay per QALY estimate over a short rolling
window to assess the dollar equivalence of this temporary condition,
treating the condition and consequently the willingness to pay as a one-
oﬀ. Next, as an example of a long-term condition, we use the work by
Eriksson et al. (2010) where the QALY eﬀect of lifestyle interventions in
reducing cardiovascular risk was examined. We applied the long-run
equivalent willingness to pay per QALY for this intervention. The
willingness to pay in this case did not include the additional willingness
to pay for not having a long-term health condition as it is unknown
from the study as to what degree cardiovascular risk is reduced. Lastly,
we use the research by Sun et al. (2010) where the substitution of whole
grains for white rice in relation to risk of type 2 diabetes was studied.
The study showed that replacing intake of white rice with whole grains
was associated with a 36% lower diabetes risk (the QALY diﬀerence
was not available). We estimate the willingness to pay for this risk re-
duction using the estimated reduction in cardiovascular risk (36%)
times the willingness to pay for not having a long-term health condi-
tion. The results are presented in Table 4.
As shown in Table 4, individual's average willingness to pay for not
having an inﬂuenza-like-illness or a clinically diagnosed ﬂu is estimated
to be around A$211. For people with high cardiovascular risk, a certain
life style intervention that could improve health-related quality of life is
estimated to be worth an average payment of A$894 per year. To lower
diabetes risk, it would be worthwhile to pay A$761 per year to replace
intake of white rice with whole grains.
If the costs of these health conditions and interventions are pro-
vided, our willingness to pay estimates can either be used to inform a
threshold for cost-eﬀectiveness analysis, or to facilitate a net-beneﬁts
approach.
5. Conclusions and discussions
Using subjective wellbeing as experienced utility, we estimate the
willingness to pay for health using equivalised disposable income in-
strumented by ﬁnancial worsening events, where health is described by
SF-6D and long-term condition status. The estimates have the potential
to facilitate the evaluation of a variety of health programmes as de-
monstrated in Section 4.3. As this method relies on questions on life
satisfaction, household income, ﬁnancial events and a generic health
status instrument which can be more easily obtained from or in-
corporated into existing large population-representative survey such as
the British Household Panel Survey (BHPS) as compared with methods
based on hypothetical and scenario-speciﬁc questions, the approach has
the potential to be replicated internationally and guide the country-
speciﬁc QALY values.
Despite the methodological and the conceptual diﬀerences, the
yielded estimates from our approach (A$42,000-A$67,000 per QALY)
are not dissimilar to the observed QALYs thresholds in decision marking
in Australia (George et al., 2001). However, it is worth highlighting that
our results indicate a further willingness to pay for not having a long-
term condition holding health-related quality of life constant, which
could be an argument for a higher threshold for long-term conditions.
Also, we derive the willingness to pay per QALY based on individual
utility maximization and interpret it as individual's average willingness
to pay. From a societal perspective, the value of health could be higher
given that some health cost such as sick leave due to a ﬂu are primarily
costs to business not individuals. Given that the method measures
willingness to pay using individual preferences, our approach also does
not consider the health system level trade-oﬀs, which has recently been
explored in Claxton et al. (2015). Such issues will need to be considered
if the estimates are adopted as basis for health care decision making.
Interestingly, the estimated willingness to pay per QALY (A$42,000)
is less than the willingness to pay per wellbeing (a change from 3 to 10
on a life satisfaction scale based on Appendix Figure S1 [INSERT LINK
TO ONLINE FILE B]) which is estimated to be approximately
A$112,000 per year over a 2-year rolling window, indicating that full
wellbeing is perceived to be worth more than just a year of life with
perfect health, or put diﬀerently that other life circumstances also
contribute signiﬁcantly to wellbeing and their impacts cannot be sub-
stituted by perfect health.
A limitation of our method is that willingness to pay for health could
be underestimated owning to the adaptation eﬀect, namely that people
with long-term conditions can revise the rating of subjective wellbeing
after adapting to the situation despite health not improving. An extreme
example of the adaptation eﬀect would be that people who become
blind in adulthood gradually have learnt to appreciate other pleasures
of life, and their life satisfaction could rise even when blindness goes on
(Ubel et al., 2000). However, this does not mean that these people are
not willing to pay large amount of money for eyesight treatment and
outcomes. The estimated willingness to pay needs to be treated with
care in such cases (for a more detailed discussion of the issue of
adaptation eﬀect, see Oswald and Powdthavee, 2008; and Loewenstein
and Ubel, 2008). We should also contemplate whether using life sa-
tisfaction to measure the value of health could distort people's intention
to report truthfully–an old concern for many other survey-based
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methods.
Also, we interpreted people's willingness to pay for health as pay for
a health gain or pay to reverse a health loss, as those who had a health
improvement would have a health loss ﬁrst given that the SF-6D is
bounded by 1. In this sense, we have implicitly assumed that the impact
of a health loss and a health gain on life satisfaction are similar, and a
health gain can bring life satisfaction back to the level prior to when the
health loss occurred, holding all else constant. This could be another
limitation of the study. We also note here that although experienced
wellbeing (life satisfaction) was used, the QALYs in this study were
generated using the SF-6D scores which were based on the currently
widely accepted stated preference weights. Whether QALYs should be
generated using other methods is beyond the scope of this study.
As this is the ﬁrst study that uses the wellbeing valuation method to
monetise the value of a QALY, we believe that future research that
replicates the method across other common health utility instruments
such as EuroQol ﬁve dimensions (EQ-5D) will be valuable. It is also of
great interest to explore how the results compare across datasets and
countries, as willingness to pay for a QALY in various countries are
most likely to be diﬀerent depending on people's perceptions of the
value of health and other life factors as well as income levels.
Acknowledgement
Appropriate approval was obtained from the Department of Social
Services (Australia) to access the publicly available, de-identiﬁed
longitudinal dataset. There are no conﬂicts of interest. We thank the
editors and two anonymous reviewers for their valuable suggestions.
Philip Clarke is funded by a National Health and Medical Research
Council Senior Research Fellowship (APP1079621).
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://dx.
doi.org/10.1016/j.socscimed.2018.06.009.
References
Australian Bureau of Statistics, 2015. 6523.0-Household income and wealth, Australia,
2013-14. Retrieved from: http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/
6523.0Explanatory%20Notes12013-14?OpenDocument.
Bilcke, J., Coenen, S., Beutels, P., 2014. Inﬂuenza-like-illness and clinically diagnosed ﬂu:
disease burden, costs and quality of life for patients seeking ambulatory care or no
professional care at all. PLoS One 9 (7), e102634.
Brazier, J., Roberts, J., Deverill, M., 2002. The estimation of a preference-based measure
of health from the SF-36. J. Health Econ. 21 (2), 271–292.
Clark, A.E., Frijters, P., Shields, M.A., 2008. Relative income, happiness, and utility: an
explanation for the easterlin paradox and other puzzles. J. Econ. Lit. 46 (1), 95–144.
Clark, A.E., Oswald, A.J., 2002. A simple statistical method for measuring how life events
aﬀect happiness. Int. J. Epidemiol. 31 (6), 1139–1144.
Claxton, K., Sculpher, M., Palmer, S., Culyer, A.J., 2015. Causes for concern: is NICE
failing to uphold its responsibilities to all NHS patients? Health Econ. 24 (1), 1–7.
Dolan, P., Kahneman, D., 2008. Interpretations of utility and their implications for the
valuation of health. Econ. J. 118, 215–234.
Eriksson, M.K., Hagberg, L., Lindholm, L., Malmgren-Olsson, E.B., Österlind, J., Eliasson,
M., 2010. Quality of life and cost-eﬀectiveness of a 3-year trial of lifestyle inter-
vention in primary health care. Arch. Intern. Med. 170 (16), 1470–1479.
Ferrer-i-Carbonell, A., van Praag, B.M.S., 2002. The subjective costs of health losses due
to chronic diseases. An alternativemodel formonetary appraisal. Health Econ. 11,
709–722.
Frijters, P., Johnston, D.W., Shields, M.A., 2011. Life satisfaction dynamics with quarterly
life event data. Scand. J. Econ. 113 (1), 190–211.
George, B., Harris, A., Mitchell, A., 2001. Cost-eﬀectiveness analysis and the consistency
of decision making: evidence from pharmaceutical reimbursement in Australia (1991
to 1996). Pharmacoeconomics 19 (11), 1103–1109.
Groot, W., van den Brink, H.M., 2004. A direct method for estimating the compensating
income variation for severe headache and migraine. Soc. Sci. Med. 58 (2), 305–314.
Hagenaars, A.J.M., de Vos, K., Zaidi, M.A., 1994. Poverty Statistics in the Late 1980s:
Research Based on Micro-data. Oﬃce for Oﬃcial Publications of the European
Communities.
Loewenstein, G., Ubel, P.A., 2008. Hedonic adaptation and the role of decision and ex-
perience utility in public policy. J. Publ. Econ. 92 (8–9), 1795–1810.
Mark, T.L., Swait, J., 2004. Using stated preference and revealed preference modeling to
evaluate prescribing decisions. Health Econ. 13 (6), 563–573.
McNamee, P., Mendolia, S., 2014. The eﬀect of chronic pain on life satisfaction: evidence
from Australian data. Soc. Sci. Med. 121, 65–73.
McPherson, K., Myers, J., Taylor, W.J., McNaughton, H.K., Weatherall, M., 2004. Self-
valuation and societal valuations of health state diﬀer with disease severity in chronic
and disabling conditions. Med. Care 42 (11), 1143–1151.
Mervin, M.C., Frijters, P., 2014. Is shared misery double misery? Soc. Sci. Med. 107,
68–77.
Moore, S., Shepherd, J.P., 2006. The cost of fear: shadow pricing the intangible costs of
crime. Appl. Econ. 38 (3), 293–300.
Oswald, A.J., Powdthavee, N., 2008. Does happiness adapt? A longitudinal study of
disability with implications for economists and judges. J. Publ. Econ. 92 (5–6),
1061–1077.
Powdthaveea, N., van den Berg, B., 2011. Putting diﬀerent price tags on the same health
condition: Re-evaluating the well-being valuation approach. J. Health Econ. 30 (5),
1032–1043.
Ryen, L., Svensson, M., 2015. The willingness to pay for a quality adjusted life year: a
review of the empirical literature. Health Econ. 24 (10), 1289–1301.
Summerﬁeld, M., Freidin, S., Hahn, M., La, N., Li, N., Macalalad, N., O'Shea, M., Watson,
N., Wilkins, R., Wooden, M., 2016. HILDA User Manual – Release 15. Melbourne
Institute of Applied Economic and Social Research. University of Melbourne.
Sun, Q., Spiegelman, D., van Dam, R.M., Holmes, M.D., Malik, V.S., Willett, W.C., Hu,
F.B., 2010. White rice, brown rice, and risk of type 2 diabetes in US men and women.
Arch. Intern. Med. 170 (11), 961–969.
Tversky, A., Kahneman, D., 1991. Loss aversion in riskless choice: a reference-dependent
model. Q. J. Econ. 106, 1039–1061.
Ubel, P.A., Richardson, J., Menzel, P., 2000. Societal value, the person trade-oﬀ, and the
dilemma of whose values to measure for cost-eﬀectiveness analysis. Health Econ. 9,
127–136.
van den Berg, B., Ferrer-i-Carbonell, A., 2007. Monetary valuation of informal care: the
well-being valuation method. Health Econ. 16 (11), 1227–1244.
Whitehurst, D.G.T., Bryan, S., Lewis, M., 2011. Systematic review and empirical com-
parison of contemporaneous EQ-5D and SF-6D group mean scores. Med. Decis.
Making 31 (6), E34–E44.
Table 4
Estimated willingness to pay for health.
Example Participant characteristics QALY impact/ long-
term condition risk
Willingness to pay
Inﬂuenza-like-illness and clinically diagnosed ﬂu
(Bilcke et al., 2014)
A general population sample who experienced 5–6 symptoms over a 6-day
period with an average episode amounted to 4 days of absence from work
or school.
Loss of 0.005 QALY A$211
Life style intervention in reducing cardiovascular
risk (Eriksson et al., 2010)
People aged 18–65 years, with hypertension, dyslipidaemia, type 2
diabetes mellitus, obesity, or any combination thereof.
Gain of 0.04 QALY over
3 years
A$894 per year
Substitution of whole grains for white rice to lower
risk of type 2 diabetes (Sun et al., 2010)
People aged 26 to 87 with no diagnoses of diabetes, cardiovascular
disease, or cancer at baseline.
A 36% lower diabetes
risk
A$761 per year
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